Literature DB >> 2472812

MS: a localized immune disease of the central nervous system.

V Calder, S Owen, C Watson, M Feldmann, A Davison.   

Abstract

The precise role of T cells in multiple sclerosis (MS) remains to be defined. No MS-specific antigen has been found. The autoimmune hypothesis for MS rests on immune changes seen in the spinal fluid and brain and on the demonstration, in an experimental animal model, that T cells raised to myelin basic protein transfer demyelination. In this review, Virginia Calder and colleagues focus on recent studies suggesting that in MS, the initial T-cell response occurs within the central nervous system and that the blood poorly reflects this immune activity. This contrasts with the animal model, experimental allergic encephalomyelitis, where the initial immune response is peripheral.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472812     DOI: 10.1016/0167-5699(89)90235-1

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  8 in total

1.  Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple sclerosis.

Authors:  Makoto Matsui; Shin-ichi Araya; Hui-Yun Wang; Kouji Matsushima; Takahiko Saida
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

2.  Susceptibility to multiple sclerosis is associated with the proximal immunoglobulin heavy chain variable region.

Authors:  M A Walter; W T Gibson; G C Ebers; D W Cox
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

Review 3.  The neuroendocrine-immune axis.

Authors:  F Homo-Delarche; M Dardenne
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Degradation of human myelin in vitro by leucocytes from patients with multiple sclerosis.

Authors:  S J Owen; C M Watson; A N Davison
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

5.  In the presence of dexamethasone, gamma interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules.

Authors:  K Bergsteindottir; A Brennan; K R Jessen; R Mirsky
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

6.  Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent: elucidation by the action of mitoxantrone.

Authors:  D Baker; J K O'Neill; A N Davison; J L Turk
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

7.  Total lymphoid irradiation in multiple sclerosis.

Authors:  C M Wiles; L Omar; A V Swan; G Sawle; J Frankel; R Grunewald; T Joannides; P Jones; H Laing; P H Richardson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

Review 8.  Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update.

Authors:  J E Merrill; M C Graves; D G Mulder
Journal:  West J Med       Date:  1992-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.